INPP5D and systemic lupus erythematosus: The recovery of SHIP-1 activity can promote B cell apoptosis, inhibit B cell proliferation, prevent B cell overactivation, and reduce inflammation in SLE patients by inhibiting ERK/SHIP-1 signaling pathway, thereby slowing down the disease.